Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

ME-3167 heading for NDA submission

March 26, 1997

Antidepressant effects of NKH-477

March 26, 1997

Cysteine protease inhibitors described by Senju

March 26, 1997

Sumitomo reveals antipsychotic agents with reduced side effects

March 26, 1997

Dolasetron effective for nausea and vomiting associated with high-dose cisplatin

March 25, 1997

Zeneca granted exclusivity for new formulation of propofol

March 25, 1997

Myotrophin scheduled for review in May

March 25, 1997

Second approval for Zomig

March 25, 1997

Topamax cleared for marketing in Canada

March 25, 1997

AIT-082 enters trials in patients in Canada

March 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...